7/22/2025Lannacheng Secures Over CNY 300M in Series C+ to Advance Radiopharma P...

7/22/2025Huadong Subsidiary Reports Strong Phase III Results for Roflumilast Cr...

7/22/2025Innovent Secures IND for Oral GLP‑1 Agonist IBI3032 as Mazdutide Hits...

7/22/2025Chimigen Raises ~CNY 170M to Advance Cancer and HepB Vaccines

7/21/2025Novo Nordisk, Fangzhou Partner on AI-Powered Diabetes, Obesity Care

7/18/2025Recent Executive Moves

7/18/2025SKBio Wins Chinese Clinical Trial Approval for GBP410

7/18/2025China Releases 2nd Batch of Clinical Guidelines for Rare Diseases, Cov...

7/18/2025China Seeks Comments on 96th Batch of Reference Formulations for Gener...

7/18/2025China Unveils New Clinical Trial Guidelines for Antibacterial Drugs Ta...

7/18/2025China Issues New Draft Guidelines for Pharmaceutical Development of Or...

7/18/2025Hengrui's SHR‑A1904 Emerges as Promising New Weapon Against Advanced ...

7/18/2025China Approves First Homegrown Oral Anti‑Influenza Drug by Zenshine P...

7/18/2025China Greenlights New Semaglutide Indication to Combat Kidney and Card...

7/18/2025China Approves Nation's First Recombinant Human Albumin Injection Deri...

7/18/2025Novartis CEO Highlights China Momentum in Q2 2025 Earnings Call

7/18/2025CMS Launches Secondary Listing in Singapore to Fuel Regional Expansion

7/18/2025China Resources Pharma Plans CNY1B Innovation Fund to Boost Pharma Gro...

7/18/2025China Launches 11th Round of VBP, Covering 55 Medicines with CNY 44B ...

7/18/2025Chinese Biotechs Drive Hong Kong IPO Boom in H12025

7/17/2025I‑Mab Deepens Bet on CLDN18.2 Bispecific by Acquiring Bridge Health

7/17/2025VivaVision Secures New CNY 140M Series D2+ Round

7/17/2025China Accepts Amgen and ONC Marketing Submission for Imdelltra in ES-S...

7/16/2025China Unveils New Atopic Dermatitis Guidelines and JAK1 Advances at Gl...

7/16/2025FDA Loosens Global Trial Standards but Keeps a Cautious Distance from ...

7/16/2025Astellas Pharma Executive Sentenced to 3½ Years in China

7/16/2025AstraZeneca Secures First-Time Clinical Trial Approvals in China for F...

7/16/2025Innovent Initiates Phase III Trial for IBI343 in Advanced Pancreatic C...

7/15/2025China Clears IND for YolTech’s First-in-Class In Vivo Base Editing Th...

7/15/2025Mabgeek Biotech's Hong Kong IPO Application Accepted, Prospectus Publi...

Page:2/54 Total number of articles:1606: [First][<<] [1] [2] [3] [4] [5] [>>] [End]